SMSPHARMA.BOSMSPHARMA.BOBSE
Loading
Year-over-year net income growth rate
Percentile
P21
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -7.27% |
| Q3 2025 | 23.53% |
| Q2 2025 | 0.86% |
| Q1 2025 | 11.37% |
| Q4 2024 | 29.38% |
| Q3 2024 | -14.44% |
| Q2 2024 | -4.63% |
| Q1 2024 | 50.51% |
| Q4 2023 | -2.09% |
| Q3 2023 | 25.51% |
| Q2 2023 | 166.10% |
| Q1 2023 | -6.74% |
| Q4 2022 | 287.43% |
| Q3 2022 | 84.27% |
| Q2 2022 | -299.20% |
| Q1 2022 | -28.49% |
| Q4 2021 | -61.08% |
| Q3 2021 | -2.27% |
| Q2 2021 | 1.84% |
| Q1 2021 | 8.15% |
| Q4 2020 | 95.03% |
| Q3 2020 | 56.10% |
| Q2 2020 | 9.93% |
| Q1 2020 | -16.08% |
| Q4 2019 | -22.94% |
| Q3 2019 | 27.25% |
| Q2 2019 | -42.05% |
| Q1 2019 | 42.33% |
| Q4 2018 | -6.36% |
| Q3 2018 | 40.29% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q3 2016 | 23.71% |
| Q2 2016 | -24.86% |
| Q1 2016 | 10.49% |
| Q4 2015 | 5.11% |